SQUAMOUS NON-SMALL CELL LUNG CANCER SQNSCLC

Clinical trials for SQUAMOUS NON-SMALL CELL LUNG CANCER SQNSCLC explained in plain language.

Never miss a new study

Get alerted when new SQUAMOUS NON-SMALL CELL LUNG CANCER SQNSCLC trials appear

Sign up with your email to follow new studies for SQUAMOUS NON-SMALL CELL LUNG CANCER SQNSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New vaccine combo takes on tough lung cancer in early trial

Disease control Not yet recruiting

This early-phase study tests a new cancer vaccine (EVM14) combined with an immunotherapy drug (ivonescimab) in 13 people with advanced squamous non-small cell lung cancer that has not been treated before. The main goals are to check safety and find the right dose, while also look…

Matched conditions: SQUAMOUS NON-SMALL CELL LUNG CANCER SQNSCLC

Phase: PHASE1 • Sponsor: Everest Medicines (Beijing) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC

SQUAMOUS NON-SMALL CELL LUNG CANCER SQNSCLC

Get alerted when new SQUAMOUS NON-SMALL CELL LUNG CANCER SQNSCLC trials appear

New vaccine combo takes on tough lung cancer in early trial